These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 28833079)

  • 1. Cancer-associated fecal microbial markers in colorectal cancer detection.
    Eklöf V; Löfgren-Burström A; Zingmark C; Edin S; Larsson P; Karling P; Alexeyev O; Rutegård J; Wikberg ML; Palmqvist R
    Int J Cancer; 2017 Dec; 141(12):2528-2536. PubMed ID: 28833079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Fecal
    Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
    Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.
    Löwenmark T; Löfgren-Burström A; Zingmark C; Eklöf V; Dahlberg M; Wai SN; Larsson P; Ljuslinder I; Edin S; Palmqvist R
    Sci Rep; 2020 Sep; 10(1):15250. PubMed ID: 32943695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
    Leung A; Tsoi H; Yu J
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
    Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
    J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.
    Xie YH; Gao QY; Cai GX; Sun XM; Sun XM; Zou TH; Chen HM; Yu SY; Qiu YW; Gu WQ; Chen XY; Cui Y; Sun D; Liu ZJ; Cai SJ; Xu J; Chen YX; Fang JY
    EBioMedicine; 2017 Nov; 25():32-40. PubMed ID: 29033369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
    Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
    United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta-analysis.
    Zhang X; Zhu X; Cao Y; Fang JY; Hong J; Chen H
    Cancer Med; 2019 Feb; 8(2):480-491. PubMed ID: 30636375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
    Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
    Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
    Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
    Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
    Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
    Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
    J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model.
    Baxter NT; Koumpouras CC; Rogers MA; Ruffin MT; Schloss PD
    Microbiome; 2016 Nov; 4(1):59. PubMed ID: 27842559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Bacterium SELEX Aptamer Selection of
    Wang N; Fan T; Chen Y; Chen H; Qin Y; Jiang Y
    Anal Chem; 2023 Aug; 95(33):12216-12222. PubMed ID: 37578005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
    Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
    Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19-9, gender, and age.
    Zhao R; Xia D; Chen Y; Kai Z; Ruan F; Xia C; Gong J; Wu J; Wang X
    Cancer Med; 2023 Jul; 12(13):14636-14645. PubMed ID: 37162269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial markers in colorectal cancer detection and/or prognosis.
    Villéger R; Lopès A; Veziant J; Gagnière J; Barnich N; Billard E; Boucher D; Bonnet M
    World J Gastroenterol; 2018 Jun; 24(22):2327-2347. PubMed ID: 29904241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbial DNA markers serve for screening colorectal neoplasm in asymptomatic subjects.
    Liang JQ; Wong SH; Szeto CH; Chu ES; Lau HC; Chen Y; Fang J; Yu J; Sung JJ
    J Gastroenterol Hepatol; 2021 Apr; 36(4):1035-1043. PubMed ID: 32633422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.